Frederiksberg, Denmark

Anja Hviid Simonsen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anja Hviid Simonsen: Innovator in Alzheimer's Disease Biomarkers

Introduction

Anja Hviid Simonsen is a prominent inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of Alzheimer's disease research through her innovative work on protein-based biomarkers. With a total of 3 patents, her inventions aim to improve the diagnosis and treatment of this debilitating condition.

Latest Patents

Anja's latest patents include groundbreaking work on Saposin D and FAM3C as biomarkers for Alzheimer's disease. These inventions provide protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. Specifically, her biomarkers can classify a subject sample as either Alzheimer's disease or non-Alzheimer's disease. The detection of these biomarkers can be achieved through SELDI mass spectrometry. Additionally, her inventions offer appropriate treatment interventions and methods for measuring response to treatment. Certain biomarkers may also be suitable for use as radio-labeled ligands in non-invasive imaging techniques such as Positron Emission Tomography (PET).

Career Highlights

Throughout her career, Anja has worked with notable companies such as Vermillion, Inc. and Vermillion Corporation. Her work has been instrumental in advancing the understanding and treatment of Alzheimer's disease.

Collaborations

Anja has collaborated with esteemed colleagues, including Huw Alun Davies and James Norton McGuire, to further her research and innovations in the field.

Conclusion

Anja Hviid Simonsen's contributions to Alzheimer's disease research through her patented biomarkers represent a significant advancement in the field. Her work not only aids in diagnosis but also paves the way for improved treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…